But are those reactions dependent on our sex?
The Enigmatic Sexually Dimorphic Brain The complex sexually dimorphic brain is an intricate puzzle from which we are piecing together similarities and differences between the sexes for disease onset, development, and progression. As many neuropsychiatric disorders have a sex bias, elucidation of what makes the male brain different from the female brain and when in development and maturation such sex differences are important may prove enlightening if we want to identify novel therapeutic targets and treatments. Sex differences are important to consider for both how the organism responds or copes with neuroendocrine or immune challenges to homeostasis, such as stress or infection, as well as for how such perturbations may then feed back to program long-term changes in future responses. This idea of a G 3 E 3 D (or how our Genes are affected by the Environment during Developmental periods) interaction has been a recent focal point of the National Institute for Mental Health and its Director, Thomas Insel. The identification of environmental programming effects on novel genes during sensitive and dynamic periods of brain development and maturation has greatly pushed forward our understanding of disease susceptibility. There is no doubt that sex factors into this equation, but its contribution at a mechanistic level has been greatly ignored. How can this be? With women presenting with affective disorders at two to three times the rate of men, with autism affecting four times as many boys as girls, and with schizophrenia and depression onset dramatically rising during the adolescent years when major sex differences in brain maturation occur, taking a closer look at why sex matters seems a question of fundamental importance.
In the absence of gonadal hormones during the sensitive period, the default brain is female.well, almost. The effect of the perinatal testosterone surge is to masculinize the male brain. In the absence of this hormonal trigger, typical differences between sexually dimorphic nuclei will likely never develop. However, application of testosterone to a female during this organizational period or to a male outside this period produces a brain that is neither fully male nor female. Not surprisingly, our chromosomal sex can also contribute to brain development in a hormone-independent manner. Evidence supporting this idea has come from many studies, including Art Arnold's development of the four core genotype mice where the testis-determining SRY gene is autosomal, providing a novel tool with which the contribution of sex chromosome complement can be dissociated from gonadal sex to address important questions regarding sex differences (Arnold and Chen, 2009) .
The timing or ''critical periods'' of brain development demarcate points where the plastic brain undergoes dramatic changes that are distinctly feminine or masculine, with sexually dimorphic nuclei increasing or decreasing in size, synapse and glia numbers changing, and dendritic spines sprouting at a rapid rate. However, an aspect of disease mechanism that has been greatly overlooked is the examination of how these sex-specific states may present as a window of vulnerability, where the normal developmental trajectory becomes most susceptible to reprogramming. For instance, in both humans and rodents, portions of the limbic system that are involved in stress regulation and emotional affect undergo significant maturation during adolescence, where amygdala volume increases significantly more in boys, while hippocampal volume increases faster in girls. Interestingly, these same limbic and forebrain regions are extremely sensitive to stress (McEwen, 2005) . Logic would follow that as glucocorticoids are potent modulators of synaptic function and plasticity, exposure to stressors during adolescence could shape these areas critical to emotionality in a sex-dependent manner (Goel and Bale, 2009) . Unfortunately, while studies have begun to focus on the long-term consequences of stress during adolescence as a predetermining factor in disease, sex-specificity for outcomes has not been included as a possible factor. As adolescence is a period of increased presentation of mental health disorders, it will be imperative to better identify and delineate these interactions between adolescent brain maturation, environmental influences, and sex.
Sex, Stress, and Affective Disorders
One example where these factors may come together to mediate brain dysfunction is the case of affective disorders. We have become increasingly aware that females are diagnosed with affective disorders at more than twice the rate of males, while we still know astonishingly little regarding potential mechanisms underlying such sex differences. Clinical studies have pinpointed stress sensitivity or stress pathway dysregulation as a strong risk factor in affective disorder onset and susceptibility. Notably, in both humans and rodents, females show a postpubertal increase in stress response magnitude and a more prolonged stress recovery time compared to males.
Orchestration of the stress response and recovery can be influenced by a host of neuroendocrine and immune factors and may have long-term consequences related to the future sensitivity and susceptibility of the organism. Therefore, the continued ability throughout life to appropriately respond to stress is a necessary aspect in homeostatic maintenance and disease prevention. Interestingly, dysregulation of the hypothalamic-pituitary-adrenal (HPA) stress axis, defined as inappropriate stress responsivity, be it too high or too low, is the most common and predictive physiological symptom in neuorpsychiatric disease. However, it is not yet clear whether changes in HPA axis hormones are a primary contributor or a secondary response to an as yet undetermined cause.
The Immunological Intersection
Interestingly, there is a recent appreciation for the direct impact of the immune system on the stress axis and its potential involvement in stress-induced affective disorder onset and progression. Why is this important now? From early work by the famed endocrinologist Hans Selye, we have long understood the role that stress axis glucocorticoids play in dampening the immune system, and in more recent studies that within the brain these same steroid hormones can enhance immune function via direct actions on microglia (Sorrells et al., 2009 [this issue of Neuron]). However, as is often the case in organismal maintenance where endocrine system feedback works to promote homeostasis, the converse also rings true-proinflammatory cytokines and immune activation are potent stimulators of the HPA stress axis and are thought to function during chronic inflammation to promote cytokine-dependent glucocorticoid receptor resistance. More directly, cytokines also have an effect on promoting release of CRF, a likely candidate for many of the symptoms presented in affective disorders (Irwin and Miller, 2007) .
Could there be sex differences in how the immune system interacts with these outcomes or in the link between inflammation and affective disorders? Certainly, there are well-examined immunosuppressive effects of the gonadal hormone rise during pregnancy, promoting a vulnerability of the pregnant host to infection (Butts and Sternberg, 2008) . However, less is understood at the cellular level as to specific innate sex differences in the ability of immune molecules to alter stress responsivity or influence affect. Interestingly, in a preponderance of human autoimmune diseases including multiple sclerosis and lupus erythematosus, there is also a sex difference with greater prevalence in women. Here too, the neuroendocrine stress axis intersects with immune function, greatly exacerbating disease symptoms.
Where do we begin for understanding the influence of neuroendocrine and immune systems on sex differences? If we first back up and examine how the sexually dimorphic brain develops, we find intriguing evidence in support of the immune system's influence on important sex differences even at the cellular level beginning very early in CNS development. Margaret McCarthy's laboratory has elegantly demonstrated in rats that brain masculinization by estrogen during the perinatal sensitive period occurs through prostaglandin-dependent mechanisms and can be blocked by a COX-2 inhibitor, supporting a critical role for neuroimmune signals in programming of the sexually dimorphic brain (Amateau and McCarthy, 2004) . So, at a very early point in development we find evidence for a critical interaction between neuroendocrine-neuroimmune pathways that is involved in establishing sex differences.
In addition to helping program the sexually dimorphic brain, the neuroimmune system also plays an important role in regulation of various neurotransmitters important in stress response throughout life. One example involves the kynurenine pathway and its potent stimulation by proinflammatory cytokines. In the brain, tryptophan is degraded by the cytokineinducible enzyme indoleamine 2,3 dioxygenase (IDO). Fluctuations of IDO activity following inflammation can have a direct effect on tryptophan availability and hence the amount of serotonin synthesized, which is clearly critical in maintenance of mental health and has been associated with the development of major depression and schizophrenia (Dantzer et al., 2008) . Since stress hormones also have direct actions on cytokine production via the glucocorticoid-induced TNF receptor to induce IDO activity, the increased stress response and reduced recovery in females could further alter tryptophan metabolism and 5-HT availability. During stress experience, reduced 5-HT production is prohibitive to adaptive coping abilities and can greatly contribute to learned helplessness, where in humans such passive responses to stress are highly associated with the occurrence of depressive symptoms. Overall, there appear to be multitudes of paths in which fundamental sex differences beginning early in brain development, through dynamic periods of maturation and throughout life, can collide to push an organism into disease susceptibility.
Clinically, understanding such sexdependent mechanisms becomes important in diagnosis as well as in designing treatments with greater efficacy. As men and women are viewed as having a distinctly different brain development and maturation, then it would follow that one drug ''size'' would not fit all. For instance, we know that in women the acute phase of antidepressant therapy frequently increases anxiety rather than decreasing it. Further, if we factor in developmental timing, where adolescence is distinct from adulthood, SSRI treatments have been associated with an increased risk for suicidal thoughts and behavior. While little has been examined as to potential sex differences in these measures, based on the dynamic state of the adolescent brain it seems a necessary question to be addressed. Here again, we turn our attention to the importance of sex differences intersecting with developmental stages when determining disease outcome.
Points of Vulnerability: The Road Less Taken
While we now understand more about the importance of gonadal hormones, chromosomal sex, and the neuroimmune system in the ''normal'' programming of the sexually dimorphic brain, the potential for early life insults to alter this trajectory and its relevance to disease are less clear. Fetal antecedents, postnatal disturbances, or childhood trauma have increasingly been associated with longterm disease risk in depression, anxiety, schizophrenia, and autism (Gardener et al., 2009; Goel and Bale, 2009; Heim et al., 2008) . However, despite an obvious sex bias in these diseases, surprisingly little has been examined as to how such early life experiences may alter perinatal or adolescent sexually dimorphic brain development and plasticity. Imaging studies in clinical evaluation of sex differences in affective disorders and schizophrenic patients have revealed dysregulation of the human neuroendocrine system with fetal antecedents coinciding with brain sexual differentiation (Goldstein, 2006) and a disruption of the normal sexually dimorphic ratio of orbitofrontal cortex to amygdala in male schizophrenia patients (Gur et al., 2004) . Such clinical findings support the need to identify contributing factors in the disruption of ''normal'' sex differences related to neurodevelopmental disease susceptibility, be they insightful markers pointing to the timing of an insult or as an underlying mechanism of disease etiology.
Insults that specifically occur during gestation have been highly associated with the development of schizophrenia and autism, where maternal stress or infection by way of increasing the proinflammatory response is thought to increase risk. Interestingly, playing right into the hypothesis that development of the sexually dimorphic brain may be involved, these diseases have been recently proposed as the hypo-or hypermasculinized brain in male patients, respectively. Studies in rodent models have examined the influence of prenatal stress on a range of sex-dependent outcomes, including hippocampal-dependent learning and memory and adult stress responsivity, illustrating the specificity of these outcomes to the timing of stress exposure across pregnancy (Mueller and Bale, 2008) . Not surprisingly, these studies support a likely feminization of males exposed to stress during early development, where spatial learning and memory, stress hormone responses, and physiological characteristics of stressed males show a pattern more similar to females. These studies suggest a possible disruption in the process of normal masculinization of the sexually dimorphic brain by maternal experience. Recent epidemiological studies found a similar association between maternal stress experience during the first trimester with an increased risk of schizophrenia in males (Khashan et al., 2008) . As the brain is less likely to be the direct target during this time, a candidate target tissue for mechanistic examination is the placenta, where influences of early gestational perturbations affecting developmental programming in humans and rodents may contribute to changes in maternal hormones or placental gene expression patterns impacting the developing embryo throughout gestation. It turns out that the placenta is actually sex specific, developing predominantly out of the embryo with less contribution from the mother. These data point to an exciting and novel involvement of chromosomal sex and a sex-specific interaction with the maternal hormonal milieu, inflammatory responses, and nutrient transport and growth support of the developing fetus.
Focusing on early programming events in disease susceptibility leads us to an important mode of regulation that has yet to be tapped for sex differencesepigenetics. The recent surge of neuroscientists incorporating epigenetics into their research demonstrates a rethinking of disease etiology. Where our tunnel vision around genetic inheritance had been limited to DNA sequence and singlenucleotide polymorphisms, an appreciation has surfaced for the contribution made by the environment and experience as also heritable through DNA methylation, histone acetylation, and microRNAs. In animal models, epigenetic analyses have been applied to the examination of long-term outcomes and transgenerational effects of maternal care, diet, stress, or infection to identify specific genes associated with disease endophenotypes (Fagiolini et al., 2009) . While a great body of work has examined the critical role for DNA methylation in the imprinting essential for normal mammalian development, we know much less about how this machinery itself is regulated and what contribution to sex-dependent outcomes it might play. Intriguing sex differences exist in the expression patterns for the epigenetic machinery tied to regulating methylation and acetylation patterns. For instance, females typically have much greater levels of DNA methyl transferase enzymes and methylbinding proteins in many tissues including the brain and placenta. Further, there are sex-chromosome-specific histone demethylases, Utx and Uty. How sex specificity in epigenetic machinery may relate to programming of the sexually dimorphic brain or potential differences in sexbiased disease is not clear but is likely again to point to developmental windows of vulnerability where gene targets could be identified.
Conclusions
At the crossroads of the developing and maturing sexually dimorphic brain and the challenges that pose a potential deviation from this norm may lie the sexspecific programming events contributing toward disease susceptibility. Studies herein afford us a great opportunity to define disease mechanisms and novel therapeutic targets and prevention. The interaction of the neuroendocrine and immune systems with brain sex is an essential component of how the organism copes and maintains homeostasis where appropriate responses are necessary in short-and long-term disease prevention. These strategies are likely to be highly individual and dependent on a host of factors, with sex being a key contributor. We have many miles to go to fully dissect this enigmatic sexually dimorphic brain and the diverse points along its route of development and maturation where detours are likely to reprogram the final destination. Of clear importance in our continuing studies is the appropriate inclusion and evaluation of sex comparisons. Perhaps in solving this puzzle a critical additional piece to the timing and environmental equation needs to be G 3 E 3 D 3 S.
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